These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10435211)

  • 1. Sodium valproate increases pupillary responsiveness to a cholinergic agonist in responders with mania.
    DeMet EM; Sokolski KN
    Biol Psychiatry; 1999 Aug; 46(3):432-6. PubMed ID: 10435211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pupillary cholinergic sensitivity to pilocarpine increases in manic lithium responders.
    Sokolski KN; DeMet EM
    Biol Psychiatry; 1999 Jun; 45(12):1580-4. PubMed ID: 10376118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic sensitivity predicts severity of mania.
    Sokolski KN; DeMet EM
    Psychiatry Res; 2000 Sep; 95(3):195-200. PubMed ID: 10974358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.
    Dilsaver SC; Swann AC; Shoaib AM; Bowers TC
    J Psychiatry Neurosci; 1993 Mar; 18(2):61-6. PubMed ID: 8461283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents.
    Bymaster FP; Felder CC
    Mol Psychiatry; 2002; 7 Suppl 1():S57-63. PubMed ID: 11986996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing peripheral and central cholinergic system responses.
    Naranjo CA; Fourie J; Herrmann N; Lanctôt KL; Birt C; Yau KK
    J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate for acute mood episodes in bipolar disorder.
    Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
    Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor.
    Dabisch PA; Horsmon MS; Muse WT; Mioduszewski RJ; Thomson S
    Toxicol Sci; 2007 Nov; 100(1):281-9. PubMed ID: 17693423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of mianserin to affect autonomic function in the pupils of depressed patients.
    Shur E; Checkley S; Delgado I
    Acta Psychiatr Scand; 1983 Jan; 67(1):50-5. PubMed ID: 6303056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of serum valproate concentration to response in mania.
    Bowden CL; Janicak PG; Orsulak P; Swann AC; Davis JM; Calabrese JR; Goodnick P; Small JG; Rush AJ; Kimmel SE; Risch SC; Morris DD
    Am J Psychiatry; 1996 Jun; 153(6):765-70. PubMed ID: 8633687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.
    Roxanas MG; Hunt GE
    Psychosomatics; 2012; 53(6):575-81. PubMed ID: 23157995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of olanzapine and sodium valproate given alone or as add-on therapy in acute mania. A comparative study.
    Kumar A; Gupta M; Jiloha RC; Tekur U
    Methods Find Exp Clin Pharmacol; 2010 Jun; 32(5):319-24. PubMed ID: 20664822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unipolar mania: a distinct entity or characteristic of manic preponderance?].
    Yazıcı O; Cakır S
    Turk Psikiyatri Derg; 2012; 23(3):201-5. PubMed ID: 22949290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.
    Bowden CL; Brugger AM; Swann AC; Calabrese JR; Janicak PG; Petty F; Dilsaver SC; Davis JM; Rush AJ; Small JG
    JAMA; 1994 Mar 23-30; 271(12):918-24. PubMed ID: 8120960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.